Tpl2 kinase signal transduction in inflammation and cancer

Cancer Lett. 2011 May 28;304(2):80-9. doi: 10.1016/j.canlet.2011.02.004. Epub 2011 Mar 5.

Abstract

The activation of mitogen-activated protein kinases (MAPKs) is critically involved in inflammatory and oncogenic events. Tumor progression locus 2 (Tpl2), also known as COT and MAP3 kinase 8 (MAP3K8), is a serine-threonine kinase with an important physiological role in tumor necrosis factor, interleukin-1, CD40, Toll-like receptor and G protein-coupled receptor-mediated ERK MAPK signaling. Whilst the full characterization of the biochemical events that lead to the activation of Tpl2 still represent a major challenge, genetic and molecular evidence has highlighted interesting interactions with the NF-κB network. Here, we provide an overview of the multifaceted functions of Tpl2 and the molecular mechanisms that govern its regulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Inflammation / enzymology*
  • Inflammation / immunology
  • MAP Kinase Kinase Kinases / immunology
  • MAP Kinase Kinase Kinases / metabolism*
  • Neoplasms / enzymology*
  • Neoplasms / immunology
  • Proto-Oncogene Proteins / immunology
  • Proto-Oncogene Proteins / metabolism*
  • Signal Transduction / physiology*

Substances

  • Proto-Oncogene Proteins
  • MAP Kinase Kinase Kinases
  • MAP3K8 protein, human